EP1100544A4 - Immunogenes cellulaires allogeniques utiles comme vaccins contre le cancer - Google Patents

Immunogenes cellulaires allogeniques utiles comme vaccins contre le cancer

Info

Publication number
EP1100544A4
EP1100544A4 EP99933855A EP99933855A EP1100544A4 EP 1100544 A4 EP1100544 A4 EP 1100544A4 EP 99933855 A EP99933855 A EP 99933855A EP 99933855 A EP99933855 A EP 99933855A EP 1100544 A4 EP1100544 A4 EP 1100544A4
Authority
EP
European Patent Office
Prior art keywords
cancer vaccines
immunogens useful
allogeneic cellular
cellular immunogens
allogeneic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99933855A
Other languages
German (de)
English (en)
Other versions
EP1100544A1 (fr
Inventor
Michael S Halpern
James M England
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALLEGHNEY UNIVERSITY OF HEALTH SCIENCES
ALLEGHNEY UNIVERSITY OF HE
Original Assignee
ALLEGHNEY UNIVERSITY OF HEALTH SCIENCES
ALLEGHNEY UNIVERSITY OF HE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALLEGHNEY UNIVERSITY OF HEALTH SCIENCES, ALLEGHNEY UNIVERSITY OF HE filed Critical ALLEGHNEY UNIVERSITY OF HEALTH SCIENCES
Publication of EP1100544A1 publication Critical patent/EP1100544A1/fr
Publication of EP1100544A4 publication Critical patent/EP1100544A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103—Receptors for growth factors
    • A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001152—Transcription factors, e.g. SOX or c-MYC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001154—Enzymes
    • A61K39/001164—GTPases, e.g. Ras or Rho
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP99933855A 1998-07-24 1999-07-08 Immunogenes cellulaires allogeniques utiles comme vaccins contre le cancer Withdrawn EP1100544A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9396598P 1998-07-24 1998-07-24
US93965P 1998-07-24
PCT/US1999/015594 WO2000004927A1 (fr) 1998-07-24 1999-07-08 Immunogenes cellulaires allogeniques utiles comme vaccins contre le cancer

Publications (2)

Publication Number Publication Date
EP1100544A1 EP1100544A1 (fr) 2001-05-23
EP1100544A4 true EP1100544A4 (fr) 2003-01-15

Family

ID=22241962

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99933855A Withdrawn EP1100544A4 (fr) 1998-07-24 1999-07-08 Immunogenes cellulaires allogeniques utiles comme vaccins contre le cancer

Country Status (3)

Country Link
EP (1) EP1100544A4 (fr)
AU (1) AU4981999A (fr)
WO (1) WO2000004927A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7198920B1 (en) 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
US7229623B1 (en) 2000-08-03 2007-06-12 Corixa Corporation Her-2/neu fusion proteins
KR100472746B1 (ko) * 2001-08-13 2005-03-07 김진우 원암 유전자 ｋｇ-20 및 이에 의해 코드되는 단백질
EP3794127A1 (fr) * 2018-05-14 2021-03-24 Vivet Therapeutics Vecteurs de thérapie génique comprenant des séquences s/mar

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031107A1 (fr) * 1994-05-13 1995-11-23 Board Of Trustees Of The University Of Illinois Strategies immunotherapeutiques appliquees dans le traitement du cancer
WO1997025860A1 (fr) * 1996-01-19 1997-07-24 Allegheny University Of The Health Sciences Immunogenes cellulaires utiles en tant que vaccins contre le cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69430824T2 (de) * 1993-08-12 2003-01-23 Neurotech S.A., Evry Biokompatible immunoisolatorische Kapseln, die genetisch veränderte Zellen enthalten

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031107A1 (fr) * 1994-05-13 1995-11-23 Board Of Trustees Of The University Of Illinois Strategies immunotherapeutiques appliquees dans le traitement du cancer
WO1997025860A1 (fr) * 1996-01-19 1997-07-24 Allegheny University Of The Health Sciences Immunogenes cellulaires utiles en tant que vaccins contre le cancer

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BACUS S S ET AL: "TUMOR-INHIBITORY MONOCLONAL ANTIBODIES TO THE HER-2/NEU RECEPTOR INDUCE DIFFERENTIATION OF HUMAN BREAST CANCER CELLS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 52, 1 May 1992 (1992-05-01), pages 2580 - 2589, XP000919492, ISSN: 0008-5472 *
HUANG A Y C ET AL: "ROLE OF BONE MARROW-DERIVED CELLS IN PRESENTING MHC CLASS I-RESTRICTED TUMOR ANTIGENS", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 264, 13 May 1994 (1994-05-13), pages 961 - 965, XP002037401, ISSN: 0036-8075 *
JOHNSON P J ET AL: "OVEREXPRESSED PP-60C-SRC CAN INDUCE FOCUS FORMATION WITHOUT COMPLETE TRANSFORMATION OF NIH-3T3 CELLS", MOLECULAR AND CELLULAR BIOLOGY, vol. 5, no. 5, 1985, pages 1073 - 1083, XP009000334, ISSN: 0270-7306 *
See also references of WO0004927A1 *
ZHU DAN ET AL: "Overexpression of CD44 in p185-neu-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion.", ONCOGENE, vol. 12, no. 11, 1996, pages 2309 - 2314, XP009000333, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
WO2000004927A1 (fr) 2000-02-03
AU4981999A (en) 2000-02-14
EP1100544A1 (fr) 2001-05-23

Similar Documents

Publication Publication Date Title
HK1105581A1 (en) Vaccine composition
HUP0202885A3 (en) Vaccines
PL351486A1 (en) Prrsv vaccines
IL145043A0 (en) Vaccine
HUS1300072I1 (hu) Vakcina
GB9910812D0 (en) Vaccine composition
PL356770A1 (en) Use of anti-idiotypical antibodies as vaccines against cancer
GB9901254D0 (en) Vaccines
GB9915204D0 (en) Vaccine
EP0923284A4 (fr) Immunogenes cellulaires utiles en tant que vaccins contre le cancer
EP1100544A4 (fr) Immunogenes cellulaires allogeniques utiles comme vaccins contre le cancer
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
GB9921347D0 (en) Novel immunogenic compositions
GB9929434D0 (en) Novel vaccine composition
GB9812316D0 (en) Cancer vaccines
GB9806736D0 (en) Manufactured cellular vaccine
GB9922700D0 (en) Vaccine
SI1229936T1 (en) Use of anti-idiotypical antibodies as vaccines against cancer
GB9906694D0 (en) Vaccine composition
GB9906696D0 (en) Vaccine composition
GB9904280D0 (en) Vaccines
GB9904048D0 (en) Vaccines
GB9915205D0 (en) Vaccine
GB9916677D0 (en) Vaccine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20021129

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20031022

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040302